Professional Documents
Culture Documents
RADIOLOGICAL
FINDINGS
IN
COVID - 19
M. Irvanie R Harahap, MD
CENTRAL ARMY HOSPITAL GATOT SOEBROTO
2020
INTRODUCTIONS
DEFINITION
COVID-19:
Coronavirus Disease 2019, An infectious
disease caused by a coronavirus species,
namely severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2), previously known
as the 2019 novel coronavirus (2019-nCoV).
Zhu et al – A Novel Coronavirus From Patients With Pneumonia in China, n engl j med 382;8 (2020)
EPIDEMIOLOGY
Dec 2019:
First case in Wuhan, China
(a seafood wholesale market)
March 2020:
Global Pandemic
March 2020:
Pandemic in Indonesia
Zhu et al – A Novel Coronavirus From Patients With Pneumonia in China, n engl j med 382;8 (2020)
EPIDEMIOLOGY
As of 16 September 2020:
The Government of Indonesia announced 228 993 (3 963 new)
confirmed cases of COVID-19, 9 100 (135 new) deaths and 164
101 recovered cases from 493 districts across all 34 provinces.
Transmission:
Viruses can be transmitted from animals to humans
(Zoonosis). The process of transmission through direct,
droplet, or faecal-oral contact. Animals that often become
hosts are bats, rats, camels and ferrets.
Shereen et al – COVID-19 infection: Origin, transmission, and characteristics of human coronaviruses, Journal
of Advanced Research 24 (2020)
Shereen et al – COVID-19 infection: Origin, transmission, and characteristics of human coronaviruses, Journal
of Advanced Research 24 (2020)
CLINICAL SYMPTOMS
The Incubation Period are 1 – 14 days.
Symptoms appear on the third to eighth day
Huang et al – Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China, Lancet 2020; 395
CLINICAL SYMPTOMS
CYTOKINE STORM:
Uncontrolled systemic inflammatory response resulting from the
release of large amounts of pro-inflammatory cytokines and
chemokines by immune effector cells in SARS-CoV infection.
Li et al – Molecular immune pathogenesis and diagnosis of COVID-19, Journal of Pharmaceutical Analysis 10 (2020).
LABORATORIES
Guan W et al - Clinical Characteristics of Coronavirus Disease 2019 in China, N Engl J Med 2020; 382:1708-1720
LABORATORIES
Hadaya J, Schumm M, Livingston EH. Testing Individuals for Coronavirus Disease 2019 (COVID-19). JAMA. 2020.
Hadaya J, Schumm M, Livingston EH. Testing Individuals for Coronavirus Disease 2019 (COVID-19). JAMA. 2020.
OPERATIONAL DEFINITIONS
Symptomatic Unsymptomatic
Cleverley et al - The role of chest radiography in confirming covid-19 pneumonia, : BMJ 2020;370:m2426
Decision tool for radiological management of patients with suspected
covid-19
Cleverley et al - The role of chest radiography in confirming covid-19 pneumonia, : BMJ 2020;370:m2426
What do we find on Chest
radiography ?
Cozzi et al
(2020) Reticular – Nodular
1 Opacities
Cozzi et al - Chest X-ray in new Coronavirus Disease 2019 (COVID-19) infection: fndings and correlation
with clinical outcome, La radiologia medica (2020).
Bilateral, both sides of the lungs.
Mainly on the lower lobes.
Distribution
Peripheral or Subpleural predominance.
Pneumothorax.
Rarely Pleural effusions.
Lymphadenopathies.
Caviations.
Cozzi et al - Chest X-ray in new Coronavirus Disease 2019 (COVID-19) infection: fndings and correlation
with clinical outcome, La radiologia medica (2020).
Reticular – Nodular Opacities
Cozzi et al - Chest X-ray in new Coronavirus Disease 2019 (COVID-19) infection: fndings and correlation
with clinical outcome, La radiologia medica (2020).
Ground glass opacity.
Cleverley et al - The role of chest radiography in confirming covid-19 pneumonia, : BMJ 2020;370:m2426
Consolidations.
Cleverley et al - The role of chest radiography in confirming covid-19 pneumonia, : BMJ 2020;370:m2426
Progressions Evaluation
Cleverley et al - The role of chest radiography in confirming covid-19 pneumonia, : BMJ 2020;370:m2426
Progressions Evaluation
DAY 10
Cleverley et al - The role of chest radiography in confirming covid-19 pneumonia, : BMJ 2020;370:m2426
How to report chest radiography
findings?
BSTI has provided reporting templates with gradings
for use in CXR during the COVID-19 pandemic
https://www.bsti.org.uk/covid-19-resources/covid-19-bsti-reporting-templates/
BSTI Grading
https://www.bsti.org.uk/covid-19-resources/covid-19-bsti-reporting-templates/
BSTI Grading (2)
https://www.bsti.org.uk/covid-19-resources/covid-19-bsti-reporting-templates/
BSTI Grading (3)
https://www.bsti.org.uk/covid-19-resources/covid-19-bsti-reporting-templates/
https://radiopaedia.org/cases/left-lower-lobe-pneumonia-1
Pneumothorax
Visible right
visceral pleural
edge is seen as a
very thin, sharp
white line and no
lung markings are
seen peripheral to
this line.
https://radiopaedia.org/cases/pneumothorax-with-apical-bleb?lang=gb
Cardiogenic
pulmonary oedema
https://radiopaedia.org/cases/cardiogenic-pulmonary-oedema-1?lang=gb
Classic / Probable
COVID-19
https://radiopaedia.org/cases/covid-19-pneumonia-95?lang=gb
Milliary Tuberculosis
Widespread randomly
distributed
innumerable tiny
nodules in both lungs.
There is no
consolidation or pleural
fluid and no
mediastinal or hilar
nodal enlargement.
https://radiopaedia.org/cases/miliary-tuberculosis-5?lang=gb
Conclusions